Austria vs New Zealand: Number of isolates tested for extended-spectrum cephalosporins
Austria
267
in 2018
New Zealand
456
in 2017
Austria rank
11th
New Zealand rank
8th
Number of isolates tested for extended-spectrum cephalosporins over time
- Austria
- New Zealand
How they compare
New Zealand currently reports 456 against 267 in Austria, a difference of 189.
That makes New Zealand's figure about 1.7 times Austria's.
Across all 9 years both countries report, New Zealand has been ahead every year.
Austria ranks 11th and New Zealand ranks 8th of 51 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 104 | 234 | 130 | New Zealand |
| 2010s | 131 | 389.38 | 258.38 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Austria or New Zealand?
- New Zealand, at 456 against 267 in Austria as of 2017.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Austria and New Zealand?
- 189, with New Zealand ahead.
- How many years of comparable data are there for Austria and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Austria and New Zealand rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Austria ranks 11th and New Zealand ranks 8th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.